文献
J-GLOBAL ID:202102271433507755
整理番号:21A0348809
分泌PD-L1変異体は非小細胞肺癌におけるPD-L1遮断療法に対する耐性を仲介する【JST・京大機械翻訳】
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer
著者 (20件):
Gong Bo
(Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Gong Bo
(Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan)
,
Kiyotani Kazuma
(Immunopharmacogenomics Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Sakata Seiji
(Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Nagano Seiji
(Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan)
,
Nagano Seiji
(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
,
Kumehara Shun
(Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan)
,
Kumehara Shun
(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
,
Baba Satoko
(Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Besse Benjamin
(INSERM U981, Gustave Roussy Cancer Campus, Universite Paris Saclay, Villejuif, France)
,
Besse Benjamin
(Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France)
,
Yanagitani Noriko
(The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Friboulet Luc
(INSERM U981, Gustave Roussy Cancer Campus, Universite Paris Saclay, Villejuif, France)
,
Nishio Makoto
(The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Takeuchi Kengo
(Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Takeuchi Kengo
(Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Kawamoto Hiroshi
(Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan)
,
Fujita Naoya
(Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Fujita Naoya
(Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan)
,
Katayama Ryohei
(Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan)
資料名:
Journal of Experimental Medicine
(Journal of Experimental Medicine)
巻:
216
号:
4
ページ:
982-1000
発行年:
2019年
JST資料番号:
A0937B
ISSN:
0022-1007
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)